Filter
32
Text search:
Monorésistance
Featured
7
10
Language
Document type
27
3
2
Countries
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
16
8
1
1
Toolboxes
26
1
1
1
Emerging Infectious Diseases; Vol. 21, No. 11, November 2015
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
3rd edition
Kiongozi cha Muwezeshaji
Technical and operational ‘how-to’: practical considerations
Annual Report: 2015-2016
A survival guide for clinicans.
3rd edition.
(updated December 2014).
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening
recommended
PLoS ONE 9(1): e87262. doi:10.1371/journal.pone.0087262
Epidemiology, Control, and Financing
Research Article
BMC Infectious Diseases 2012, 12:262; doi:10.1186/1471-2334-12-262
Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB
Results of the first national survey, 2013–2014
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
